2516246-24-3

2516246-24-3 structure
2516246-24-3 structure
  • Name: FtsZ-IN-1
  • Chemical Name: FtsZ-IN-1
  • CAS Number: 2516246-24-3
  • Molecular Formula: C26H32IN3
  • Molecular Weight: 513.46
  • Catalog: Signaling Pathways Anti-infection Bacterial
  • Create Date: 2022-06-30 23:43:17
  • Modify Date: 2025-08-25 10:48:09
  • FtsZ-IN-1 is a potent FtsZ inhibitor with quinolinium ring. FtsZ-IN-1 has stronger antibacterial activity against Gram-positive bacteria with MICs of 0.5-8 μg/mL. FtsZ-IN-1 significantly causes cell elongation of B. subtilis by enhancing FtsZ polymerization. FtsZ-IN-1 exhibits low hemolytic toxicity and low tendency to induce drug resistance. FtsZ-IN-1 has against drug-resistant bacteria activity[1].

Name FtsZ-IN-1
Description FtsZ-IN-1 is a potent FtsZ inhibitor with quinolinium ring. FtsZ-IN-1 has stronger antibacterial activity against Gram-positive bacteria with MICs of 0.5-8 μg/mL. FtsZ-IN-1 significantly causes cell elongation of B. subtilis by enhancing FtsZ polymerization. FtsZ-IN-1 exhibits low hemolytic toxicity and low tendency to induce drug resistance. FtsZ-IN-1 has against drug-resistant bacteria activity[1].
Related Catalog
Target

FtsZ[1]

In Vitro FtsZ-IN-1 (compound A3) inhibits effectively the growth of S. aureus with MICs of 0.5-1 μg/mL, and generally displays less antibacterial potency against most Gram-negative bacteria tested such as E. coli ATCC 8739 (MIC = 64 μg/mL) and P. Aeruginosa ATCC 27853 (MIC >64 μg/mL)[1]. FtsZ-IN-1 exhibits MBCs of 4-8 μg/mL and MICs of 1-4 μg/mL against S. aureus, B. subtilis and E. faecium[1]. FtsZ-IN-1 (0-24 μg/mL; 24 hours) inhibits the growth of S. aureus in a bacteriostatic mode at 1×, 2×, 4× MIC concentrations, and kills S. aureus at 8× MIC concentration[1]. FtsZ-IN-1 can restore the antibacterial activity of methicillin against MRSA in a synergistic manner, with MIC of 2 μg/mL[1]. FtsZ-IN-1 (2 μg/mL; 4 hours) can enlarge cell size of B. subtilis and inhibits bacterial cell division[1]. FtsZ-IN-1 (0-15 μg/mL; 48 hours) exhibits IC50s of 12.77 and 9.42 μg/mL in L929 and HK-2 cells[1]. FtsZ-IN-1 (2 μg/mL) can effectively delay the induction of drug resistance[1]. Cell Cytotoxicity Assay Cell Line: L929 and HK-2 cells[1] Concentration: 0-15 μg/mL Incubation Time: 48 hours Result: Exhibited IC50s of 12.77 and 9.42 μg/mL in L929 and HK-2 cells.
In Vivo FtsZ-IN-1 (1-64 μg/mL; 1 hour) exhibits low hemolytic toxicity in mice erythrocytes (from Kunming mice) with IC5 of 64 μg/mL[1].
References

[1]. Zhong DX, She MT, Guo XC, et al. Design and synthesis of quinolinium-based derivatives targeting FtsZ for antibacterial evaluation and mechanistic study. Eur J Med Chem. 2022;236:114360.

Molecular Formula C26H32IN3
Molecular Weight 513.46
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.